PVR and acute myeloid leukemia: Consistent with the U937 AML model, CD155 CAR-T cells effectively inhibited leukemic growth and improved survival in the CD155+ MOLM13 AML model, whereas no effect was observed in the CD155-KO AML model (Supplemental Figure 3, D–F).